Understanding Menopause: Abrupt Physiological Changes and Potential Therapies

Uncovering Menopause Dynamics

Researchers in Israel have explored the sudden and comprehensive changes women experience during menopause. The study identifies this phase as a ‘physiological cliff,’ highlighting rapid alterations across various body systems.

Menopause marks the cessation of menstrual periods for 12 months or longer, typically occurring around age 52 in the U.S. However, it can happen anytime between ages 45 to 55 or older. Observations suggest that menopausal hormone therapy might mitigate some of these abrupt changes.

Study Findings on Physiological Changes

The study reviewed over 300 million laboratory tests from over one million women across the U.S. and Israel spanning 25 years. Researchers found gradual hormonal shifts beginning approximately a decade before menopause, with acceleration leading to a significant change at the final menstrual period.

Anti-Müllerian hormone and estradiol began declining rapidly around 15 and 12 years before menopause, respectively. Conversely, the follicle-stimulating hormone increased around 14 years before menopause. The abrupt transformations spanned sex hormones, bone health, liver and kidney function, blood chemistry, and fats.

Impact of Menopause on Body Systems

These sudden shifts involve systems affected by estrogen. For instance, bone mineral density drops by about half a standard deviation, increasing risks for osteoporosis. By age 70, approximately 25% of women may have osteoporosis, leading to potential fractures and associated mortality.

Liver function also shows rapid shifts, elevating risks for liver disease. Heart disease risk factors, such as lipids and triglycerides, notably increase. A positive note is the improvement in iron, hemoglobin, and anemia reduction due to the cessation of menstrual bleeding.

Menopausal Hormone Therapy’s Role

Women undergoing menopausal hormone therapy showed reduced impacts across bodily measures, particularly in bone, liver, and kidney functions. This therapy aims to balance estrogen and progesterone levels, decreasing symptoms like hot flushes, night sweats, sleep disturbances, and anxiety.

Alon emphasized the observational nature of these findings, underscoring the necessity of clinical trials to validate hormone therapy’s efficacy. Specific medical conditions may preclude some women from treatment, necessitating personalized assessments.

Implications for Women’s Health

Alon encourages maintaining healthy habits such as exercise and nutrition, especially before the final menstrual period. Consulting healthcare providers is advised for those with risk factors for bone, heart, or liver diseases.

Future clinical trials may expand the use of hormone therapy to prevent disease progression associated with menopause.